Neuroscience
Brain
100%
In Vivo
59%
Major Depressive Disorder
49%
Multiple Sclerosis
41%
Bipolar Disorder
26%
Antidepressant
23%
Emotion
21%
White Matter
21%
Anxiety
19%
Positron Emission Tomography
16%
Psychiatry
15%
Atypical Antipsychotic
14%
Dopamine
13%
Hypothalamus
13%
μ-Opioid Receptor
11%
C-Reactive Protein
11%
Dopamine Receptor D3
11%
Genotype
11%
Methylene Blue
11%
Duloxetine
11%
5-HTTLPR
11%
Myelin
11%
Magnetic Resonance Imaging
11%
Body Mass Index
11%
Mood Disorder
11%
Magnetization Transfer
11%
Molecular Imaging
11%
Serotonin Release
11%
Neurotrauma
11%
Neuroendocrinology
11%
Acetate
11%
Psilocybin
11%
Drug Abuse
11%
Cell Excitability
9%
Gray Matter
9%
Hostility
8%
Frontal Lobe
7%
Alcohol Abuse
7%
Risperidone
7%
Thalamus
7%
Prefrontal Cortex
7%
Decanoic Acid
7%
Cerebellum
6%
Olanzapine
6%
Putamen
5%
Glucocorticoid Receptor
5%
Phenomenology
5%
Beck Depression Inventory
5%
Quetiapine
5%
Clozapine
5%
Medicine and Dentistry
Therapeutic Procedure
46%
Patient
35%
Symptom
21%
Protein
17%
Emotion
17%
Volunteer
15%
Age
12%
Disease
12%
Brain
11%
Multiple Sclerosis
11%
Aggression
11%
Follow up
11%
Diagnosis
11%
Evolution
11%
Patient with Depression
11%
Subclinical Hypothyroidism
11%
Psychiatric Diagnosis
11%
Acid
11%
Psilocybine
11%
Negative Affectivity
11%
Carbon Dioxide Breathing
11%
Hallucinogen
11%
Recurrent Disease
7%
Prophylaxis
7%
Magnetization Transfer
7%
DSM-IV
6%
Mitochondrial Membrane Transport Protein
5%
Lesion
5%
Acidosis
5%
Neuron
5%
Pharmacology, Toxicology and Pharmaceutical Science
Olanzapine
35%
Normal Human
28%
Atypical Antipsychotics
25%
Dexamphetamine
25%
Tolerability
25%
Antipsychotic
19%
Risperidone
18%
Schizophrenia
18%
Clinical Trial
17%
Carfentanil
15%
Aripiprazole
12%
Clinical Pharmacokinetics
11%
Toxic Injury
11%
Clinical Pharmacology
11%
Pharmacotherapy
11%
Cariprazine
7%
Asenapine
7%
Iloperidone
7%
Pharmacodynamics
6%
Preclinical Study
5%
Subjective Effects
5%
